Wordt geladen...
Current and emerging biomarkers in metastatic colorectal cancer
BACKGROUND: The incorporation of novel biomarkers into therapy selection for patients with metastatic colorectal cancer (mcrc) has significantly improved outcomes. Optimal treatment planning now takes into account diverse characteristics of patients and their tumours to create personalized therapeut...
Bewaard in:
| Gepubliceerd in: | Curr Oncol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Multimed Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6878935/ https://ncbi.nlm.nih.gov/pubmed/31819705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.5719 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|